Table 1 Patients' demographics (n = 102)
Variables | Value (% or range) |
|---|---|
Age (mean, standard deviation) | 43.7 years, 12.4 |
  <55 years/ ≥55 years | 83 (81.4)/ 19 (18.6) |
Female/ Male | 68 (66.7)/ 34 (33.3) |
Tumor size (median, interquartile range) | 1.2 cm, 0.9 |
  ≤1cm/ >1cm | 38 (37.3)/ 64 (62.7) |
T stage | |
 T1a/ T1b / T2 | 38 (37.3)/ 31 (30.4)/ 10 (9.8) |
 T3a/ T3b/ T4a | 0/ 9 (8.8)/ 14 (13.7) |
Multiplicity | 28 (27.5) |
Bilaterality | 21 (20.6) |
N stage | |
 N0/ N1a/ N1b | 22 (21.6)/ 41 (40.2)/ 39 (38.2) |
Chronic lymphocytic thyroiditis | 32 (31.4) |
Gross extrathyroidal extension | 23 (22.5) |
Stage | |
 I/ II/ III | 85 (83.3)/ 11 (10.8)/ 6 (5.9) |
PSMA expression | |
 Negative/ Weak | 31 (30.4)/ 20 (19.6) |
 Moderate/ Strong | 20 (19.6)/ 31 (30.4) |
Radioactive iodine therapy | 85 (83.3) |
Recurrence | 51 (50.0)) |
 Central neck | 11 (10.8) |
 Central neck plus lateral neck | 8 (7.8) |
 Lateral neck | 29 (28.4) |
 Lung | 2 (2.0) |
 Lung plus central and lateral neck | 1 (1.0) |
Median follow up period | 55.5 months (range, 13–122 months) |